Status:

COMPLETED

Myoelectrically Controlled Augmented Reality and Gaming for the Treatment of Phantom Limb Pain

Lead Sponsor:

Integrum

Collaborating Sponsors:

Sahlgrenska University Hospital

Region Örebro County

Conditions:

Phantom Limb Pain

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The goal of the clinical investigation is to reduce phantom limb pain (PLP), painful condition affecting 70% of amputees, so as to improve these patients' quality of life.

Detailed Description

The goal of the clinical investigation is to reduce phantom limb pain (PLP), a painful condition affecting 70% of amputees, so as to improve these patients' quality of life. Traditionally, mirror box ...

Eligibility Criteria

Inclusion

  • Amputee patients older than 18 years.
  • The patient has signed a written informed consent.
  • Patients must have been treated with at least one of the following therapies:
  • Conventional mirror training
  • Transcutaneous electrical stimulation (TENS)
  • Acupuncture
  • Self-hypnosis
  • Drug-based
  • The last session of previous therapies (1 and 2) must be at least 1 month before beginning the treatment here proposed.
  • In the case of drug-based treatments (5), the patient must report no PLP reduction for at least 1 month under the drug-based treatment and no variations on the medicaments dose. Any pain reduction potentially attributed to the drug-based treatment must be at least 3 months old.
  • At least a portion of biceps and triceps muscles must be present.

Exclusion

  • Patient must not have a significant cognitive impairment that prevents them from following instructions.
  • Upper limb amputees excluding shoulder disarticulation.
  • Obese patient will not be automatically excluded, however, an evaluation in the system is required to analyse if sufficient electromyography signals can be recorded.
  • Stump pain over 2 VAS of pain.
  • Participating in any other clinical study that could interfere with the result in the ongoing study.
  • Condition associated with risk of poor protocol compliance.
  • Any other condition or symptoms preventing the patient from entering the study, according to the investigator´s judgement.

Key Trial Info

Start Date :

September 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2016

Estimated Enrollment :

14 Patients enrolled

Trial Details

Trial ID

NCT02281539

Start Date

September 1 2014

End Date

January 1 2016

Last Update

May 27 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Rehabilitation Center for Upper Limb Prosthetics

Gothenburg, Sweden